Cargando…
Genome-Scale Analysis Identified NID2, SPARC, and MFAP2 as Prognosis Markers of Overall Survival in Gastric Cancer
BACKGROUND: Gastric cancer is the most common gastrointestinal tumor, and the rates of recurrence and metastasis are high. Research results on molecular biomarkers used for prognosis of gastric cancer remain inconclusive. This study aimed to explore the gene expression module of gastric cancer and t...
Autores principales: | Shan, Zexing, Wang, Wentao, Tong, Yilin, Zhang, Jianjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006563/ https://www.ncbi.nlm.nih.gov/pubmed/33758160 http://dx.doi.org/10.12659/MSM.929558 |
Ejemplares similares
-
TPX2 Promotes Metastasis and Serves as a Marker of Poor Prognosis in Non-Small Cell Lung Cancer
por: Zhou, Fang, et al.
Publicado: (2020) -
CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapy
por: Tong, Yilin, et al.
Publicado: (2021) -
Correlation Between High Expression of FOXA2 and Improved Overall Survival in Ovarian Cancer Patients
por: Shang, Hui, et al.
Publicado: (2021) -
Identification of Potential Biomarkers Associated with Prognosis in Gastric Cancer via Bioinformatics Analysis
por: Li, Dong, et al.
Publicado: (2021) -
Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases
por: Cheng, Xiaohu, et al.
Publicado: (2020)